ArabicChineseEnglishFrenchRussianSpanish
WHO home
All WHO This site only
 

Global Alert and Response (GAR)

  Country activities | Outbreak news | Resources | Media centre
  WHO > Programmes and projects > Global Alert and Response (GAR) > Diseases covered by EPR > Meningococcal disease

Meningococcal disease

:: Risk of epidemic meningitis in Africa: a cause for concern
Weekly Epidemiological Record 9 March 2007, vol. 82, 10 (pp 77–88)

- Impact of the problem
- International Coordinating Group (ICG) on Vaccine Provision
- W135 strain of the disease
- Country support
- Information resources
- Epidemiological information

Meningococcal disease, also referred to as cerebrospinal meningitis is a contagious bacterial disease caused by the meningococcus (Neisseria meningitidis). It is spread by person-to-person contact through respiratory droplets of infected people. There are 3 main clinical forms of the disease: the meningeal syndrome, the septic form and pneumonia. The onset of symptoms is sudden and death can follow within hours. In as many as 10-15% of survivors, there are persistent neurological defects, including hearing loss, speech disorders, loss of limbs, mental retardation and paralysis.

N. meningitidis inhabits the mucosal membrane of the nose and throat, where it usually causes no harm. Up to 5-10% of a population may be asymptomatic carriers. These carriers are crucial to the spread of the disease as most cases are acquired through exposure to asymptomatic carriers. Waning immunity among the population against a particular strain favours epidemics, as do overcrowding and climatic conditions such as dry seasons or prolonged drought and dust storms. Smoking, mucosal lesions and concomitant respiratory infections are considered risk factors that may contribute to the development of the disease. The disease mainly affects young children, but is also common in older children and young adults.

The disease occurs sporadically throughout the world with seasonal variations and accounts for a proportion of endemic bacterial meningitis. However, the highest burden of the disease is due to the cyclic epidemics occurring in the African meningitis belt.

for more information

- WHO fact sheet on Meningococcal meningitis
- Disease Outbreak News: meningococcal disease
- International travel and health: meningococcal disease

HIGHLIGHTS

Meningitis season 2007-2008: moderate levels of meningitis activity

Improved meningitis vaccine for Africa could signal eventual end to deadly scourge
Successful vaccine trial promises long-term, low-cost protection from epidemics in Africa

Risk of epidemic meningitis in Africa: a cause for concern [pdf 877kb]

Meeting the public health challenge of epidemic meningitis in Africa
Full text

Réseau de la méningite épidémique

Méningite épidémique: bilan de la saison 2003-2004

DISEASE OUTBREAKS

20 November 2009
Avian influenza - situation in Egypt - update 24

20 November 2009
Pandemic (H1N1) 2009 - update 75

18 November 2009
Dengue fever in Cape Verde - update 1

Disease Outbreak News